[1]. Ren A et al., Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer. Int J Cancer. 2019 Jul 1;145(1):154-163. PMID: 30561001

[2]. Shen Y et al., Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET. Int J Cancer. 2019 Feb 1;144(3):651-664. PMID: 30289981

[3]. Xu H et al., Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma. Clin Cancer Res. 2019 Jan 4. pii: clincanres.2363.2018. PMID: 30610101 

[4]. Li B et al., HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with its Natural Antisense Transcript lncHOXC-AS3. Stem Cells. 2018 Oct 23. PMID: 30353595

[5]. Shi J et al., Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma. Mol Pharm. 2018 Sep 4;15(9):4139-4147. PMID: 30048594

[6]. Li B et al., Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018 Oct;37(41):5508-5519. PMID: 29895968

[7]. Yuan Y et al., Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Int J Cancer. 2018 Jul 10. PMID:  29987896

[8]. Yu J et al., Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018 Jun;68(6):1214-1227. PMID: 29378234

[9]. Zhang N et al., SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Cell Death Differ. 2018 Jul 9. PMID: 29988076

[10]. Du L et al., CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis. Cell Death Dis. 2018 Jun 18;9(7):714. PMID: 29915309

[11]. Zhou P et al., Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. J Exp Clin Cancer Res. 2017 Sep 2;36(1):115. PMID:28865485

[12]. Wang X et al., Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Int J Cancer. 2017 Jun 28. PMID: 28656647

[13]. Li Y et al., An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017 Aug 24;8(1):347. PMID: 28839186

[14]. Wang C et al., An Indel Polymorphism within pre-miR3131 Confers Risk for Hepatocellular Carcinoma. Carcinogenesis. 2017;38:168-76. PMID:28034876

[15]. Wang X et al., Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2. Cell Death Dis. 2016;7(12):e2517. PMID:27929537

[16]. Li P et al., CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin. Oncogenesis. 2017 Apr 24;6(4):e322. PMID:28436991

[17]. Du J et al., A CRISPR/Cas9-Based Screening for Non-Homologous End Joining Inhibitors Reveals Ouabain and Penfluridol as Radiosensitizers. Mol Cancer Ther. 2018 Feb;17(2):419-431. PMID: 28864683

[18]. Chen L et al., Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.Nat Commun. 2017 Jul 17;8:16066. PMID:28714476

[19]. Li H et al., HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma. Cancer Lett. 2018 Sep 28;432:121-131. PMID: 29890207

[20]. Lu-Hua Zhang et al., TRIM24 Promotes Stemness and Invasiveness of Glioblastoma Cells via Activating SOX2 Expression. Neuro Oncol. 2020 Jun 3;noaa138. PMID: 32492707

[21]. Ke Nie et al., COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells. Oncogenesis. 2020 May 15;9(5):51. PMID: 32415061 

[22]. Si-Jing Li et al., Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner. Cancers (Basel). 2020;12(12):3864. PMID: 33371368

[23]. Xiaolong Zhang et al., Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment. Cancer Sci. 2020;111(10):3802-3812. PMID: 32691974 

[24]. Xiaoying Hou et al., Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway. Front Pharmacol. 2018;9:21. PMID: 29472856

[25]. Biao Geng et al., Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37(1):208. PMID: 30165890

[26]. Tao Gui et al., TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death Differ. 2021 Jun 26. PMID: 34175897

[27]. Jie Xiong et al., SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential. EBioMedicine. 2021 Oct 7;72:103614. PMID: 34628354

[28]. Haitao Zhang et al., A subcellular map of the human kinome. Elife. 2021 May 14;10:e64943. PMID: 33988507

[29]. Shourong Wu et al., Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway. Cancer Res. 2018 Aug 15;78(16):4549-4562. PMID: 29921695

[30]. Huiying Han et al., piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL. Blood. 2021 Mar 25;137(12):1603-1614. PMID: 32967010

[31]. Sha Song et al., IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma. Oncogene. 2021 Sep;40(35):5393-5402. PMID: 34274946

[32]. Xin Chen et al., Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice. Mol Cancer Ther. 2022 Jan;21(1):149-158. PMID: 34725191

[33]. Sichong Han et al., miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression. Biochem Pharmacol. 2021 Jun;188:114539. PMID: 33819468

[34]. Huai Wang et al., PICT1 is critical for regulating the Rps27a-Mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer. Biochim Biophys Acta Mol Cell Res. 2021 Sep;1868(10):119084. PMID: 34166715

[35]. Ke Gong et al., Gap junctions mediate glucose transfer to promote colon cancer growth in three-dimensional spheroid culture. Cancer Lett. 2022 Jan 28;531:27-38. PMID: 35093426

[36]. Li-Juan Deng et al., 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. J Ethnopharmacol. 2021 Feb 10;266:113443. PMID: 33022344

[37]. Herong Cui et al., Tetrahydropalmatine triggers angiogenesis via regulation of arginine biosynthesis. Pharmacol Res. 2021 Jan;163:105242. PMID: 33075491

[38]. Xingwen Wang et al., lncRNA HITT inhibits metastasis by attenuating Rab5-mediated endocytosis in lung adenocarcinoma. Mol Ther. 2022 Jan 8;S1525-0016(22)00014-4. PMID: 35017116

[39]. Yiran Liang et al., DGUOK-AS1 acts as a tumor promoter through regulating miR-204-5p/IL-11 axis in breast cancer. Molecular Therapy Nucleic Acids. Vol. 23 December 2021

[40]. Xiwang Yang et al., LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival. Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):e2110428119. PMID: 35091468

[41]. Xingzhou Wang et al., Estrogen Receptor Beta Prevents Signet Ring Cell Gastric Carcinoma Progression in Young Patients by Inhibiting Pseudopodia Formation via the mTOR-Arpc1b/EVL Signaling Pathway. Front Cell Dev Biol. 2021 Jan 21;8:592919. PMID: 33553141

[42]. Caiqiong Liu et al., Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy. Front Pharmacol. 2021 Apr 16;12:658236. PMID: 33935780

[43]. Sichong Han et al., Identifying the p65-Dependent Effect of Sulforaphene on Esophageal Squamous Cell Carcinoma Progression via Bioinformatics Analysis. Int J Mol Sci. 2020 Dec 23;22(1):60. PMID: 33374641

[44]. Renjian Xie et al., Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.Int J Mol Sci. 2022 Jan 12;23(2):794. PMID: 35054979

[45]. Fuwei Cheng  et al., Enhanced effect of recombinant adenoviruses co-expression of ING4 and OSM on anti-tumour activity of laryngeal cancer. J Cell Mol Med. 2022 Jan 24. PMID: 35075768

[46]. Yong Yi et al., MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β-catenin and predicts poor prognosis. Liver Int. 2021 Jun;41(6):1409-1420. PMID: 33506565

[47]. Qiang Hou et al., Identification and Functional Validation of Radioresistance-Related Genes AHNAK2 and EVPL in Esophageal Squamous Cell Carcinoma by Exome and Transcriptome Sequencing Analyses. Onco Targets Ther. 2021 Feb 18;14:1131-1145. PMID: 33633453

[48]. Li Liang et al., Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer. Cancer Cell Int. 2021 Feb 25;21(1):135. PMID: 33632198

[49]. Bing Yao et al., PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med. 2021 Apr 14;13(1):58. PMID: 33853662

[50]. Dong Zhao et al., iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation. Oncogene. 2022 Feb 15. PMID: 35169254

[51]. Xuan Deng et al., A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. Cell Death Dis. 2021 May 13;12(5):485. PMID: 33986248

[52]. Wenjie Ge et al., Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB. Cell Death Discov. 2021 Jul 26;7(1):195. PMID: 34312379

[53]. Huijing Yin et al., Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness. Nat Commun. 2021 Jul 9;12(1):4230. PMID: 34244494

[54]. Hai-Yan Peng et al., PrPC Promotes Endometriosis Progression by Reprogramming Cholesterol Metabolism and Estrogen Biosynthesis of Endometrial Stromal Cells through PPARα Pathway. Int. J. Biol. Sci. 2022, Vol. 18

[55]. Xiaoqing Zhang et al., NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44. Oncogene. 2021 Sep;40(35):5427-5440. PMID: 34282273

[56]. Qiongya Zhao et al., GRP75 Regulates Mitochondrial-Supercomplex Turnover to Modulate Insulin Sensitivity. Diabetes. 2022 Feb 1;71(2):233-248. PMID: 34810178

[57]. Shun Li et al., Simultaneous 2D and 3D cell culture array for multicellular geometry, drug discovery and tumor microenvironment reconstruction. Biofabrication. 2021 Aug 31;13(4). PMID: 34407511